Zimmer Biomet Holdings, Inc. (ZBH) Stock Grade

About Zimmer Biomet Holdings, Inc.'s fundamentals

Zimmer Biomet is a $17.7 billion medical device company with modest revenue growth of 7.2% year-over-year and a net profit margin of 8.6%, indicating reasonable profitability relative to sales. The company trades at a P/E ratio of 25.3, which is elevated compared to many industrial peers, while generating a return on equity of 5.6%, suggesting moderate efficiency in deploying shareholder capital. The company returns capital to shareholders through a 1.1% dividend yield, though this represents a relatively modest payout relative to its valuation.